ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain
NCT00981578 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37
Last updated 2020-03-11
Summary
A study to evaluate the safety and initial effectiveness of the ExAblate 2100 Conformal Bone System in the treatment of pain resulting from metastatic bone tumors.
Conditions
Interventions
- DEVICE
-
ExAblate 2100
Conformal Bone System
Sponsors & Collaborators
-
InSightec
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2016-11-14
- Completion
- 2016-11-14
Countries
- United States
Study Locations
More Related Trials
-
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
NCT01871766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
NCT02522611 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
NCT03295981 ·Status: RECRUITING ·Phase: PHASE3
-
Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma
NCT01795430 ·Status: WITHDRAWN ·Phase: NA
-
Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery
NCT02278744 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)
NCT06367972 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide
NCT02805725 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stem Cell Transplantation for Metastatic Solid Tumors
NCT00001880 ·Status: TERMINATED ·Phase: PHASE2
-
Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer
NCT01407341 ·Status: TERMINATED ·Phase: PHASE1
-
Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma
NCT04158141 ·Status: TERMINATED ·Phase: PHASE3
-
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer
NCT00004087 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma
NCT00580372 ·Status: COMPLETED ·Phase: PHASE2
-
External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease
NCT06572605 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
NCT01204203 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis
NCT02443103 ·Status: TERMINATED ·Phase: NA
-
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
NCT02306161 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma
NCT05312411 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Pemetrexed in Patients With Advanced Neuroendocrine Tumors
NCT00424723 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms
NCT02163226 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
NCT00003852 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma
NCT00004006 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
NCT00002522 ·Status: COMPLETED ·Phase: PHASE2
-
High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
NCT00002630 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain
NCT03523351 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
NCT03858205 ·Status: RECRUITING ·Phase: NA